Nahdi Medical Company (TADAWUL:4164)

Nahdi Medical Company Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16,666	15,288	17,810	21,736	-	-
Market Cap Growth	-21.63%	-14.16%	-18.06%	-	-	-
Enterprise Value	17,284	16,025	17,991	22,301	-	-
Last Close Price	128.20	114.59	128.31	151.45	-	-
PE Ratio	19.77	18.63	19.95	24.48	-	-
Forward PE	19.09	17.51	20.42	23.26	-	-
PS Ratio	1.70	1.62	2.04	2.52	-	-
PB Ratio	6.80	5.91	7.23	9.69	-	-
P/TBV Ratio	7.00	6.07	7.39	9.90	-	-
P/FCF Ratio	12.52	13.27	18.51	15.33	-	-
P/OCF Ratio	9.94	10.25	13.53	13.03	-	-
PEG Ratio	8.89	6.95	6.59	3.46	-	-
EV/Sales Ratio	1.76	1.70	2.07	2.59	-	-
EV/EBITDA Ratio	10.71	14.18	15.24	18.71	-	-
EV/EBIT Ratio	18.99	18.38	18.73	22.31	-	-
EV/FCF Ratio	12.98	13.91	18.70	15.73	-	-
Debt / Equity Ratio	0.66	0.59	0.48	0.52	0.85	0.59
Debt / EBITDA Ratio	0.99	0.99	0.76	0.74	0.93	0.85
Debt / FCF Ratio	1.21	1.33	1.22	0.82	1.29	0.96
Asset Turnover	1.61	1.64	1.69	1.87	1.80	1.95
Inventory Turnover	3.40	3.85	4.07	4.47	4.26	4.77
Quick Ratio	0.47	0.55	0.66	0.80	0.42	0.78
Current Ratio	1.39	1.55	1.69	1.70	1.40	1.72
Return on Equity (ROE)	35.37%	32.51%	37.93%	46.16%	44.13%	43.96%
Return on Assets (ROA)	9.32%	9.44%	11.64%	13.54%	12.65%	13.64%
Return on Capital (ROIC)	15.03%	14.05%	17.04%	19.61%	18.04%	19.12%
Return on Capital Employed (ROCE)	22.10%	20.90%	25.70%	29.10%	30.20%	29.70%
Earnings Yield	5.06%	5.37%	5.01%	4.08%	-	-
FCF Yield	7.99%	7.53%	5.40%	6.52%	-	-
Dividend Yield	4.22%	4.80%	4.29%	3.51%	-	-
Payout Ratio	84.79%	87.12%	80.10%	33.83%	155.07%	63.01%
Buyback Yield / Dilution	-	-	-	-	-	-2500.00%
Total Shareholder Return	4.26%	4.80%	4.29%	3.51%	-	-2500.00%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.